RLMD Relmada Therapeutics, Inc.: Net earnings per share (EPS TTM)

Graphic logo of Relmada Therapeutics Inc (RLMD)

Net losses and the risk of equity dilution drive a negative hypothesis, which is confirmed by the trend of the rolling annual EPS. The value of -0.76 captures the metric level amid competition with market behemoths and a potential funding shortfall. Meanwhile, high macro-resilience and stable demand for neuropreparations regardless of crises support the long-term potential of Relmada Therapeutics (RLMD).

RLMD (Relmada Corp) Earnings per share for the last 12 months history from 07/04/2022 to 11/14/2026

Analytical breakdowns for Relmada Therapeutics Inc (RLMD)

- current quotes and average value forecast:
Price Chart Relmada Therapeutics|RLMD - Consensus Target
- company stock capitalization data:
Market Capitalization Relmada Therapeutics, Inc.|RLMD - Enterprise Value
- business book valuation details:
Book Value per Share Relmada Therapeutics|RLMD - Accounting Capitalization|Market Capitalization to Book Value Ratio relmada.com|RLMD - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Relmada Therapeutics|RLMD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Relmada|RLMD - Company Cumulative Indebtedness|Debts to Book Capitalization Relmada Therapeutics, Inc.|RLMD - Company Long-Term Loans and Borrowings|Company Short-Term Debts Relmada Therapeutics|Quick Liquidity relmada.com
- net income and valuation multiples indicators:
RLMD - Final Profit|Projected Future Earnings Relmada Therapeutics|RLMD - P/E Multiple|Future Price to Earnings Relmada Therapeutics, Inc.|RLMD - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Relmada Therapeutics, Inc.|RLMD - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Relmada Therapeutics|RLMD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months relmada.com|RLMD - Net earnings per one share growth for the current year|Earnings growth forecast for next year Relmada Therapeutics
- sales volume and revenue information:
RLMD - Company Gross Revenue|Projected Sales Volume Relmada Therapeutics|RLMD - Market Cap to Revenue|Price-to-Projected Revenue Ratio Relmada Therapeutics, Inc.
Summary company analytics:Relmada Therapeutics (RLMD)
Flagship merchandise of Relmada Corp

Earnings per share (EPS TTM) determines the actual investor income allocated to a single security. This metric aggregates annual profit, excluding distortions caused by capital changes through share issuances or buybacks. Analyzing the EPS TTM history allows for an assessment of asset monetization efficiency. For Relmada Therapeutics (RLMD), this parameter reflects the financial stability of its virtual biotech model. Minimizing the carbon footprint and conducting laboratory audits optimize operating expenses, thereby impacting the bottom line.

Competing companies

BIIB - Earnings per share for the last twelve months|neurocrine.com (NBIX) - Net earnings per share for the last 12 months|RGC: Net earnings per share (EPS TTM)|Axsome (AXSM) - Net earnings per share (EPS TTM)|ACAD (ACADIA Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months XENE (Xenon Corp)|Net earnings per share (EPS TTM) VKTX|Net earnings per share (EPS TTM) supernus.com (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year DNLI|HRMY: Net earnings per share for the last 12 months|Biohaven Corp - Earnings per share for the last four quarters|AMLX: Net earnings per share (EPS TTM)|trevitherapeutics.com - Earnings per share for the trailing year|PRAX (Praxis Precision Medicines, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex AVXL|Earnings per share for the last twelve months CeriBell Corp (CBLL)|PRTA (Prothena Biosciences) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector)|Net earnings per share (EPS TTM) annexonbio.com ANNX|OMER - Earnings per share for the last twelve months|Earnings per one share for the last 12 months NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Corp (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share (EPS TTM) scilexholding.com|Net earnings per share for the last 12 months TVGN (Tevogen Bio)|Earnings per share for the last four quarters ACOG|Net earnings per share (EPS TTM) CGTX (Cognition Therapeutics)|Net earnings per share for the last four quarters Inhibikase Pharma (IKT)|Cassava Sciences, Inc. - Net earnings per share (EPS TTM)|Assertio Holdings, Inc. (ASRT) - Net earnings per share for the last 12 months|coyatherapeutics.com (COYA) - Earnings per share for the last twelve months|VTGN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ovid Therapeutics Inc|ABOS: Earnings per share for the trailing year|Earnings per share for the last twelve months CervoMed Inc. (CRVO)|Earnings per share for the last twelve months ATHE (alteritytherapeutics.com)|Earnings per share for the last twelve months Clene CLNN|PEPG - Net earnings per share for the last 12 months|Jupiter Neurosciences Inc - Net earnings per share (EPS TTM)|ANVS (Annovis Bio Corporation) - Earnings per share for the last 12 months|gracetx.com (GRCE) - Earnings per share for the last twelve months|Earnings per share for the last 12 months AIFF|KLTO (ANEW Medical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NeuroSense Therapeutics, Ltd. NRSN|Net earnings per share for the last 12 months RVPH (Reviva Pharmaceuticals Holdings)|Net earnings per share (EPS TTM) metaviatx.com (MTVA)|Earnings per share for the last twelve months NeurAxis, Inc. NRXS|Earnings per share for the trailing year HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics Inc.|Minerva Neurosciences Corp (NERV) - Earnings per share for the last twelve months|Athira Pharma Corp - Earnings per share for the trailing year|ADXN (Addex Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Alzamend ALZN|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|Earnings per share for the last twelve months PTIX (protagenic.com)|Earnings per share for the last twelve months Pasithea Therapeutics Corp. KTTA|CRGT - Net earnings per share for the last 12 months|Avenue Therapeutics - Net earnings per share (EPS TTM)|BCLI - Net earnings per share (EPS TTM)|CARA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CHRO|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Intra-Cellular|Net earnings per share for the last 12 months LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Earnings per share for the trailing year|NKGen Biotech - Net earnings per share for the last 12 months|Earnings per share for the last four quarters NRBO (NeuroBo Pharmaceuticals Inc)|Sage Therapeutics, Inc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc)|TRVN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vigil Neuroscience, Inc. (VIGL)|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year